Technology
Microbial enzyme is helping to churn out scarce COVID drug at complete tilt
Nature, Printed on-line: 11 March 2022; doi:10.1038/d41586-022-00675-6
Synthesis of the COVID-19 antiviral molnupiravir is more uncomplicated and extra environment friendly when a bacterial enzyme is at the process.
#Microbial #enzyme #is helping #churn #scarce #COVID #drug #complete #tilt